To evaluate the associations between maternal medication use during pregnancy and the risk of various childhood cancers, including leukemia, lymphomas, and CNS tumors.
Key Findings:
Up to 90% of pregnant women are prescribed medication, yet its impact on childhood cancer risk is unclear, raising concerns about safety.
Existing observational studies report inconsistent findings regarding the association between maternal medication use and childhood cancer, which complicates clinical decision-making.
Interpretation:
The review highlights the need for further research to clarify the potential risks associated with maternal medication use during pregnancy, particularly focusing on specific medications and their long-term implications for childhood cancer.
Limitations:
Inconsistent findings in existing observational studies may lead to uncertainty in risk assessment.
Potential biases in study designs and data collection methods could skew results and affect the reliability of conclusions drawn.
Conclusion:
This comprehensive review aims to fill the gap in understanding the relationship between maternal medication use during pregnancy and childhood cancer risk, emphasizing the necessity for more rigorous studies to inform public health guidelines.
